NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
1-Year Est. Return
12.08%
1 Year Est. Return
+12.08%
AUM
$1.31B
AUM Growth
-$337M
(-20%)
Holding
34
Top Buys
| 1 | +$10.6M | |
| 2 | +$10.6M | |
| 3 | +$7.7M | |
| 4 |
ArriVent BioPharma
AVBP
|
+$6.5M |
| 5 |
Vaxcyte
PCVX
|
+$6.23M |
Top Sells
| 1 | +$138M | |
| 2 | +$24.5M | |
| 3 | +$24M | |
| 4 |
Alibaba
BABA
|
+$10.6M |
| 5 |
Mersana Therapeutics
MRSN
|
+$6.08M |
Sector Composition
| 1 | Healthcare | 50.89% |
| 2 | Technology | 14.07% |
| 3 | Financials | 9.29% |
| 4 | Consumer Discretionary | 3.75% |
| 5 | Industrials | 0.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vanguard Total Stock Market ETF
VTI
$542B
| $285M | 21.71% |
1,038,550
|
|
||
2
Brookfield
BN
$101B
| $122M | 9.29% |
2,330,830
-468,000
|
|
||
3
Edgewise Therapeutics
EWTX
$1.84B
| $118M | 8.95% |
5,350,000
+350,000
|
|
||
4
ASML
ASML
$393B
| $110M | 8.36% |
165,836
|
|
||
5
Salesforce
CRM
$228B
| $73.2M | 5.57% |
272,801
-21,100
|
|
||
6
Mirum Pharmaceuticals
MIRM
$3.51B
| $67.6M | 5.14% |
1,500,000
|
|
||
7
Insmed
INSM
$39.2B
| $55.3M | 4.21% |
724,666
|
|
||
8
Recursion Pharmaceuticals
RXRX
$2.24B
| $51.1M | 3.89% |
9,665,128
-449,505
|
|
||
|
9
Alibaba
BABA
$386B
| $49.2M | 3.75% |
372,327
-80,000
|
|
||
10
Crinetics Pharmaceuticals
CRNX
$3.76B
| $42.8M | 3.25% |
1,275,000
+314,785
|
|
||
11
BioMarin Pharmaceuticals
BMRN
$9.78B
| $34.6M | 2.63% |
490,000
|
|
||
|
12
ArriVent BioPharma
AVBP
$729M
| $34.6M | 2.63% |
1,872,142
+351,515
|
|
||
|
13
Vaxcyte
PCVX
$5.35B
| $34.6M | 2.63% |
915,000
+165,000
|
|
||
14
Merus
MRUS
$7.22B
| $33.2M | 2.53% |
789,129
+39,129
|
|
||
15
Viridian Therapeutics
VRDN
$2.56B
| $30.3M | 2.31% |
2,250,300
+300
|
|
||
16
Pharvaris
PHVS
$1.39B
| $27.1M | 2.06% |
1,725,000
|
|
||
17
Amicus Therapeutics
FOLD
$2.7B
| $22.4M | 1.71% |
2,750,000
+250,000
|
|
||
18
Celldex Therapeutics
CLDX
$1.5B
| $21.8M | 1.66% |
1,200,000
+200,000
|
|
||
|
BPMC
19
DELISTED
Blueprint Medicines
BPMC
| $20.3M | 1.54% |
228,804
+53,804
|
|
||
|
ZBIO
20
Zenas BioPharma
ZBIO
$1.47B
| $17.5M | 1.33% |
2,214,967
+614,967
|
|
||
|
CBLL
21
CeriBell Inc
CBLL
$419M
| $16.9M | 1.29% |
880,000
+551,191
|
|
||
|
VERV
22
DELISTED
Verve Therapeutics
VERV
| $13.7M | 1.04% |
3,000,000
+600,000
|
|
||
23
Rocket Pharmaceuticals
RCKT
$329M
| $7.34M | 0.56% |
1,100,000
|
|
||
24
4D Molecular Therapeutics
FDMT
$472M
| $6.3M | 0.48% |
1,950,000
+450,000
|
|
||
25
Lexeo Therapeutics
LXEO
$579M
| $3.9M | 0.3% |
1,122,581
|
|